Latest Malin News & Updates

See the latest news and media coverage for Malin. We track all announcements, press releases, and industry mentions in real time, all in one place.

Malin

Publicly listed life sciences investment company

malinplc.com

Headquarters: Dublin 2, Ireland
Founded year: 2015
Company type: Public company
Number of employees: 10–50

Last updated Today

Latest news about Malin

In short: Malin's CEO departed as the company's portfolio contracted and assets fell following a €150M shareholder buyback and significant share tender offers.

Company announcements

January 23 Malin

Sanofi announces positive phase 3 results for amlitelimab

Amlitelimab met key endpoints in SHORE and COAST 2 studies for atopic dermatitis treatment. Sanofi plans global regulatory submissions in H2 2026.

18 November 2025 Malin

Mycovia announces publication of 2-year VIVJOA efficacy results

The VIOLET Phase 3 extension study showed 98% of women remained infection-free versus 82% on placebo for nearly two years. VIVJOA is FDA-approved for RVVC in non-reproductive potential women.

19 February 2025 Malin

Malin launches tender offer for €150 million

The offer at €10.30 per share closes 20 March 2025, pending shareholder approval at EGM on 13 March 2025.

9 December 2024 Malin

Malin reports positive interim phase 1 results for Poseida therapies

The data highlight P-BCMA-ALLO1 and P-CD19CD20-ALLO1 therapies' efficacy and safety in multiple myeloma and B-cell malignancies with ongoing clinical trials.

Media coverage

March 27 The Globe and Mail

Malin shareholders back all resolutions at 2026 AGM

Malin Corporation plc, the Ireland-based life sciences investment company listed on Euronext Growth Dublin, targets innovative healthcare businesses worldwide, backing firms built on strong scientific...

March 10 Business Post

Iseq ends trading up over 2.8%, with Malin and Bank of Ireland leading the gains

The Iseq All Share ended Tuesday trading up nearly 3 per cent, with Bank of Ireland... February was a month of two halves for investors...

February 26 The Irish Times

Malin CEO to leave and chair take on executive role as portfolio shrinks

Malin Corporation said its chief executive Fiona Dunlevy is leaving the Dublin-listed life sciences investment company as the value of its investments shrank by 80...

6 October 2025 MSN

The Malin Projects $20 Million Revenue

Malin expects to generate $20 million in revenue this year, signaling strong demand for its premium workspaces and amenities amid a crowded market for flexible...

Never miss news about Malin

Track Malin and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Malin competitors & trending companies

Browse news for competitors to Malin and other trending companies.